ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaarTaiho Oncology Europe GmbH
Taiho Oncology Europe GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Taiho Oncology Europe GmbH is the development, manufacture and marketing of cancer medications and other pharmaceuticals, particularly in the fields of oncology, allergology and urology. The company focuses on researching and developing innovative cancer treatments and also offers consumer products for healthcare.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Taiho Oncology Europe GmbH

✓ Offered7
Oncology medicines
Commercialised and developed anti-cancer therapies for solid tumours and haematological malignancies; including orally available agents and targeted agent approaches.
Medical Information
Medical information for Taiho products by email; central contact point for enquiries on available products and medical information.
Research and Development
Research and development of oncology agents; preclinical research, clinical development and chemical-pharmacokinetic expertise.
Investigator Initiated Trials
Support and review of investigator-initiated trials; online portal for application submission and status queries, scientific, safety and budget-related review.
Partnering
Licensing and acquisition of late-stage development and marketed oncology products; collaboration on small molecules, biomarkers and clinical development.
Grants & Sponsorships
Funding for external clinical research and support for scientifically sound proposals, CME providers, non-profit organisations and hospitals.
Ordering commercialised products in Europe
Order processing for commercialised Taiho products in Austria, France, Germany and Spain; enquiries for additional countries via Medical Information.
Trust & reputation

ranQ Trust Score of Taiho Oncology Europe GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Taiho Oncology Europe GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Taiho Oncology Europe GmbH scores 71.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.64.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Taiho Oncology Europe GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Taiho Oncology Europe GmbH scores 94.3 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.94.34%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Taiho Oncology Europe GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Taiho Oncology Europe GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Taiho Oncology Europe GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Taiho Oncology Europe GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Taiho Oncology Europe GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 12
6340 Baar

At a glance

Legal form
Limited Liability Company
UID
CHE-434.201.981
Founded
2021 · 5 years
Last commercial register change
November 18, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SA
    Scalepharm AG
    Baar
    AP
    Aalto Pharma AG
    Baar
    GA
    GlaxoSmithKline AG Zweigniederlassung Baar/Zug
    Baar
    SG
    Stallergenes Greer International AG
    Baar
    C(
    Cytokinetics (Switzerland) GmbH
    Zug
    CT
    Corcept Therapeutics Switzerland GmbH
    Zug
    MP
    Mirum Pharmaceuticals AG
    Zug
    OP
    Orion Pharma AG
    Zug